Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04986865
Title A Study of Evaluating the Safety and Efficacy of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (PROBE)
Acronym PROBE
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Antengene Biologics Limited
Age Groups: adult | senior
Covered Countries USA | AUS

No variant requirements are available.